The Centers for Medicare & Medicaid Services late last year introduced the Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) Model to expand access to select ...
Notable healthcare policies taking effect in 2026 will reshape hospital operations, reimbursement, insurance markets and patient access nationwide.
The Centers for Medicare and Medicaid Services has awarded Utah $195 million to strengthen rural health and medical care in fiscal year 2026, under the federal Rural Health Transformation Program.
CMS will end health equity and social drivers of health reporting requirements for its end-stage renal disease quality reporting and incentive programs on Dec. 31. CMS administers the End-Stage Renal ...
Pharmacies have quietly shipped roughly three billion dollars in unneeded prescription drugs to Medicare beneficiaries, ...
Government entities threw CV specialists for a loop in 2025 with changes that will inevitably affect patient care.
Vivant Health announced today that its Accountable Care Organization (Vivant Health ACO) has achieved more than ten million dollars in total shared savings over the most recent three performance years ...
Our study assessed the impact of using Control-IQ technology, an automated insulin delivery system, on achievement of a Healthcare Effectiveness Data and Information Set (HEDIS) quality measure ...
Introduction Clinical decision support systems (CDSS) are used to improve clinical and service outcomes, yet evidence from low- and middle-income countries (LMICs) is dispersed. This protocol outlines ...
CMS proposes Medicare coverage for legal CBD products, a move welcomed by patient advocates but complicated by looming federal hemp restrictions. A key federal health agency revealed last week that it ...
This document describes performance measures for chronic coronary disease that are appropriate for public reporting or pay-for-performance programs. Quality measures are also provided that are not yet ...
The Centers for Medicare and Medicaid Services on Tuesday announced lower prices on 15 costly prescription drugs under Medicare, including Ozempic and Wegovy. The price cuts come through the Medicare ...